EFFECT OF RIPPLE LOAD ON THE STRESS-CORROSION CRACKING IN STRUCTURAL STEELS
The presence of small ripple loading can, under certain circumstances, significantly reduce time-to-failure and threshold stress intensity for stress-corrosion cracking (SCC) of steels. A predictive framework for such ripple-loading effects (RLE) is developed from concepts and descriptors used in SCC and corrosion fatigue characterisation. The proposed framework is capable of defining critical conditions required for the occurrence of RLE and predicting time-to-failure curves. The agreement between the predicted and laboratory data is excellent.
Hydrogen Assisted Cracking of High Strength Alloys
Abstract : Two important advances over the past 40 years enable the optimization and management of the structural integrity of components in high performance applications. First, the solid mechanics conununity established linear elastic fracture mechanics as the premier framework for modeling the damage tolerance of fracture critical components (Irwin and Wells, 1997; Paris, 1998). Second, materials scientists developed metals with outstanding balances of high tensile strength and high fracture toughness (Garrison, 1990; Wells, 1993; Boyer, 1993; Starke and Staley, 1995; Olson, 1997; Kolts, 1996). An example of achievable strength-toughness properties is provided in Fig. 1, a plot of plane strain fracture toughness vs. tensile yield strength (sigma-YS) for ultra-high strength steels (UHSS) and beta-Ti alloys precipitation hardened with a phase (Gangloff 2001). New nano-scale characterization and high performance computational methods provide for additional advances in the mechanical performance properties of structural metals. These modem alloys and analysis tools satisfy technological needs for optimization and management of component performance in demanding fatigue and fracture critical applications in the aerospace, marine, energy, transportation, and defense sectors.
Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects
This study was designed to investigate the human absorption, disposition, and mass balance of 14C-brivaracetam, a novel high affinity SV2A ligand with potent anticonvulsant activity. Six healthy male subjects received a single p.o. dose of 14C-brivaracetam (150 mg, 82 μCi, or 3.03 MBq). Serial blood and complete urine and feces were collected until 144 h postdose. Expired air samples were obtained until 24 h. Brivaracetam was rapidly absorbed, with Cmax of 4 μg/ml occurring within 1.5 h of dosing. Unchanged brivaracetam amounted to 90% of the total plasma radioactivity, suggesting a modest first-pass effect. Plasma protein binding of radioactivity was low (17.5%). Urinary excretion exceeded 90% after 2 days, and the final mass balance reached 96.8% of the radioactivity in urine and 0.7% in feces. Only 8.6% of the radioactive dose was recovered in urine as unchanged brivaracetam, the remainder being identified as non–cytochrome P450 (P450)- and P450-dependent biotransformation products resulting from hydrolysis of the amide moiety (M9, 34.2%), hydroxylation of the n-propyl side chain (M1b, 15.9%), and a combination of these two pathways leading to the hydroxy acid (M4b, 15.2%). Minor amounts of taurine and glucuronic acid conjugates and other oxidized derivatives were also identified. Brivaracetam is completely absorbed, is weakly bound to plasma proteins, extensively biotransformed through several metabolic pathways, and eliminated renally.